Biomark Diagnostics Inc. (CSE:BUX)
 0.3400
 -0.0050 (-1.47%)
  Oct 31, 2025, 9:31 AM EDT
Biomark Diagnostics Revenue
Biomark Diagnostics had revenue of 38.99K CAD in the quarter ending June 30, 2025, with 1.77% growth. This brings the company's revenue in the last twelve months to 154.90K, down -4.26% year-over-year. In the fiscal year ending March 31, 2025, Biomark Diagnostics had annual revenue of 154.22K, down -5.52%.
Revenue (ttm) 
 154.90K
Revenue Growth 
 -4.26%
P/S Ratio 
 211.71
Revenue / Employee 
 n/a
Employees 
 n/a
Market Cap 
32.79M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Mar 31, 2025 | 154.22K | -9.00K | -5.52% | 
| Mar 31, 2024 | 163.22K | 9.73K | 6.34% | 
| Mar 31, 2023 | 153.49K | 109.56K | 249.38% | 
| Mar 31, 2022 | 43.93K | - | - | 
| Mar 31, 2021 | - | - | - | 
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| Curaleaf Holdings | 1.75B | 
| dentalcorp Holdings | 1.62B | 
| Trulieve Cannabis | 1.62B | 
| Green Thumb Industries | 1.57B | 
| Extendicare | 1.51B | 
| Verano Holdings | 1.16B | 
| WELL Health Technologies | 1.12B | 
| Sienna Senior Living | 929.68M |